Shahrzad Sheikhhasani, Aghdas Abdolrazaghnejad, Azam sadat Mousavi, Setareh Akhavan, Narges Zamani, & Elham Feizabad. (2023). Resistance to Single-agent Chemotherapy for Low-risk Gestational Trophoblastic Neoplasia. Babol University of Medical Sciences.
Chicago Style (17th ed.) CitationShahrzad Sheikhhasani, Aghdas Abdolrazaghnejad, Azam sadat Mousavi, Setareh Akhavan, Narges Zamani, and Elham Feizabad. Resistance to Single-agent Chemotherapy for Low-risk Gestational Trophoblastic Neoplasia. Babol University of Medical Sciences, 2023.
MLA (9th ed.) CitationShahrzad Sheikhhasani, et al. Resistance to Single-agent Chemotherapy for Low-risk Gestational Trophoblastic Neoplasia. Babol University of Medical Sciences, 2023.
Warning: These citations may not always be 100% accurate.